Recent Articles
Medicare versus Medicaid: Key differences
Lost a tooth? What to know about dental implants
Hyperbaric oxygen therapy: Evidence-based uses and unproven claims
Gatorade. Liquid IV. Do you need extra electrolytes?
Sexual violence can cast a long shadow on health
Prostate cancer: Short-course radiation just as effective as longer-term treatments
Eggs, protein, and cholesterol: How to make eggs part of a heart-healthy diet
Can a quick snooze help with energy and focus? The science behind power naps
Autism: The challenges and opportunities of an adult diagnosis
Hospice care: Overview of a compassionate approach to end-of-life care
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Men's Health
New study recommends immediate radiation when PSA Levels spike after prostate cancer surgery
Cancer
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Men's Health
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Charlie Schmidt
Treating the primary tumor can improve survival in men whose prostate cancer has spread
Cancer
Treating the primary tumor can improve survival in men whose prostate cancer has spread
Cancer
New urine test predicts high-grade prostate cancer
Charlie Schmidt
New urine test predicts high-grade cancer
Cancer
The risks of active surveillance for men with intermediate-risk prostate cancers
Men's Health
Risks of active surveillance for men with intermediate-risk prostate cancers
Charlie Schmidt
Long-term hormonal therapy benefits men with locally advanced prostate cancer
Cancer
Long-term hormonal therapy benefits men with locally advanced prostate cancer
Men's Health
Promising results for a targeted drug in advanced prostate cancer
Charlie Schmidt
Does fewer PSA tests mean less prostate cancer?
Cancer
Does fewer PSA tests mean less prostate cancer?
Cancer
Active surveillance is safe for low-risk prostate cancers
Cancer
Active surveillance is safe for low-risk prostate cancers
Men's Health
Following low-risk prostate cancers before starting treatment becoming more common
Cancer
Following low-risk prostate cancers before starting treatment becoming more common
Cancer
Heart-healthy diet boosts survival in men with low-risk prostate cancer
Cancer
The Department of Defense wages war on prostate cancer
Cancer
Hormone therapy works best when combined with radiation for locally advanced prostate cancer
Cancer
Targeted prostate biopsies better at detecting dangerous cancers
Cancer
How to monitor prostate cancer using active surveillance
Charlie Schmidt
Forms of radiation therapy for prostate cancer
Recent Articles
Medicare versus Medicaid: Key differences
Lost a tooth? What to know about dental implants
Hyperbaric oxygen therapy: Evidence-based uses and unproven claims
Gatorade. Liquid IV. Do you need extra electrolytes?
Sexual violence can cast a long shadow on health
Prostate cancer: Short-course radiation just as effective as longer-term treatments
Eggs, protein, and cholesterol: How to make eggs part of a heart-healthy diet
Can a quick snooze help with energy and focus? The science behind power naps
Autism: The challenges and opportunities of an adult diagnosis
Hospice care: Overview of a compassionate approach to end-of-life care
